Trademark Overview
On Monday, May 12, 2025, a trademark application was filed for +E-PATH with the United States Patent and Trademark Office. The USPTO has given the +E-PATH trademark a serial number of 99181122. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, May 12, 2025. This trademark is owned by Inspirata, Inc.. The +E-PATH trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Downloadable cloud-based software for use in pathology reporting, enhance data extraction, and improved operational efficiency for healthcare providers, life sciences organizations and research institutions.
Medical analysis services for the diagnosis of cancer; Providing medical profiles and medical record analysis and assessments via a website that are designed to provide custom tailored outputs about recommended resources and treatments associated with a defined set of symptoms and concerns; Providing medical information in the field of cancer diagnostics and pathology; Medical analysis services relating to the treatment of patients; Providing medical information, consultancy and advisory services; Consultancy in the field of the medical diagnosis of cancer using pathology software in clinical workflows; Medical diagnostic testing, monitoring and reporting services
Software as a service (SAAS) services featuring software using artificial intelligence (AI) for use in cancer diagnosis, pathology, and clinical research; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for automating and standardizing pathology report extraction, analysis, and interpretation; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for providing temporary use of non-downloadable software for enhancing clinical workflows in oncology and pathology; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for managing and interpreting pathology data and integrating it with healthcare systems; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for software development and maintenance for cancer diagnostics and pathology services